Overview
Dr. Paul Ladenson is a professor of medicine at the Johns Hopkins University School of Medicine. He is also a professor of oncology; pathology; and radiology and radiological science. His areas of clinical expertise include Thyroid diseases, Endocrine & Metabolic disorders. Dr. Ladenson is the John Eager Howard Professor of Endocrinology and Metabolism. He earned his M.D. from Harvard Medical School. He completed his residency and performed a fellowship in endocrinology, diabetes and metabolism at Massachusetts General Hospital. Dr. Ladenson's research interests include cardiac actions of thyroid hormone, thyroid cancer and thyroid hormone analogs. He was recognized with the Lewis E. Braverman Lectureship Award at the 82nd Annual Meeting of the American Thyroid Association (ATA) in 2012.
Dr. Ladenson is rated as an Experienced provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Thyroid Nodule, Secondary Adrenal Insufficiency, Neuroendocrine Tumor, Non-Alcoholic Fatty Liver Disease, and Thyroidectomy.
His clinical research consists of co-authoring 50 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
601 North Caroline Street, Floor 7, Floor 7, Baltimore, MD 21287
10751 Falls Road, Falls Concourse STE 412, Lutherville, MD 21093
601 North Caroline Street, Floor 3, Baltimore, MD 21287
Additional Areas of Focus
Dr. Ladenson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Medstar Medical Group Ii LLC
Kenneth Burman is an Endocrinologist in Washington, Washington, D.c.. Dr. Burman is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Medullary Thyroid Carcinoma, Anaplastic Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).
Johns Hopkins Outpatient Center
Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as a Distinguished provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.
Johns Hopkins Outpatient Center
David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Thyroid NoduleDr. Ladenson isDistinguished. Learn about Thyroid Nodule.
- Experienced
- Neuroendocrine TumorDr. Ladenson isExperienced. Learn about Neuroendocrine Tumor.
- Secondary Adrenal InsufficiencyDr. Ladenson isExperienced. Learn about Secondary Adrenal Insufficiency.
- ThyroidectomyDr. Ladenson isExperienced. Learn about Thyroidectomy.